Given the waning opportunities to hit the jackpot with a blockbuster, markets that target diseases with small patient populations or modest revenue potential are of increasing interest to big pharmas. Windhover’s upcoming Therapeutic Area Partnerships event will feature unpartnered assets for a range of diverse diseases, including some aimed at niche markets, in a “Hot Space” meeting track.
The meeting, to be held from Nov. 30 to Dec. 2 in Boston, gives companies with promising assets the opportunity to make a case for their candidates’ potential. Assets are...